FDA Pauses Obesity Drug Study; Diabetic Eye Therapy OK’d; ‘Misleading’ Super Bowl Ad

[ad_1]

(MedPage Today) — The FDA ordered a clinical hold on a phase I study of the investigational obesity drug AMG 513, said developer Amgen.
Children’s Hospital Los Angeles has paused initiation of puberty blockers for transgender patients under age…

[ad_2]

Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/114175

Author :

Publish date : 2025-02-11 17:47:45

Copyright for syndicated content belongs to the linked Source.